JNJ seeking Topamax monotherapy approval

JNJ submitted an sNDA to the FDA for Topamax topiramate as a monotherapy to treat epilepsy. Topamax is approved outside the U.S. as monotherapy, and in the U.S. for use in combination with other anti-...